Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma

被引：88

作者：

Cheah, Chan Yoon ^{[1
]}

Nastoupil, Loretta J. ^{[1
]}

Neelapu, Sattva S. ^{[1
]}

Forbes, Sheryl G. ^{[1
]}

Oki, Yasuhiro ^{[1
]}

Fowler, Nathan H. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

来源：

BLOOD | 2015年 / 125卷 / 21期

关键词：

D O I：

10.1182/blood-2015-03-633156

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：3357 / 3359

页数：5

相关论文

共 6 条

[1]

[Anonymous], 2015, ZYD ID TABL OR US PR

[2]

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia [J].

Furman, Richard R. ;

Sharman, Jeff P. ;

Coutre, Steven E. ;

Cheson, Bruce D. ;

Pagel, John M. ;

Hillmen, Peter ;

Barrientos, Jacqueline C. ;

Zelenetz, Andrew D. ;

Kipps, Thomas J. ;

Flinn, Ian ;

Ghia, Paolo ;

Eradat, Herbert ;

Ervin, Thomas ;

Lamanna, Nicole ;

Coiffier, Bertrand ;

Pettitt, Andrew R. ;

Ma, Shuo ;

Stilgenbauer, Stephan ;

Cramer, Paula ;

Aiello, Maria ;

Johnson, Dave M. ;

Miller, Langdon L. ;

Li, Daniel ;

Jahn, Thomas M. ;

Dansey, Roger D. ;

Hallek, Michael ;

O'Brien, Susan M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (11) :997-1007

[3]

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma [J].

Gopal, Ajay K. ;

Kahl, Brad S. ;

de Vos, Sven ;

Wagner-Johnston, Nina D. ;

Schuster, Stephen J. ;

Jurczak, Wojciech J. ;

Flinn, Ian W. ;

Flowers, Christopher R. ;

Martin, Peter ;

Viardot, Andreas ;

Blum, Kristie A. ;

Goy, Andre H. ;

Davies, Andrew J. ;

Zinzani, Pier Luigi ;

Dreyling, Martin ;

Johnson, Dave ;

Miller, Langdon L. ;

Holes, Leanne ;

Li, Daniel ;

Dansey, Roger D. ;

Godfrey, Wayne R. ;

Salles, Gilles A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (11) :1008-1018

[4]

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma [J].

Quach, H. ;

Ritchie, D. ;

Stewart, A. K. ;

Neeson, P. ;

Harrison, S. ;

Smyth, M. J. ;

Prince, H. M. .

LEUKEMIA, 2010, 24 (01) :22-32

[5]

Smith S, BLOOD, V124

[6]

PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances [J].

So, Lomon ;

Fruman, David A. .

BIOCHEMICAL JOURNAL, 2012, 442 :465-481